Static Chart Sarepta Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
131.8 ^USD	-0.36%		-1.38%	+36.70%

May. 02	Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says	MT
May. 02	UBS Adjusts Price Target on Sarepta Therapeutics to $173 From $167, Maintains Buy Rating	MT

Duration

Period